E100-33M-00: Abbott SJM Epic Bioprosthetic Heart Valve, Mitral 33mm

Sign in to add this product to your favorites!
Price: | $5,349.00 per box of 1 |
---|---|
Quantity: | |
In Stock: | 2 box of 1 |
Expiration: | 10-2025 (or later) |
Additional Details
Abbott Epic Mitral Bioprosthetic Heart Valve – E100 Series
The Abbott Epic™ Mitral Bioprosthetic Heart Valve (item #E100 series) is a stented porcine tissue valve designed for mitral valve replacement in patients with diseased, damaged, or malfunctioning native or prosthetic mitral valves. The valve features a flexible polymer stent, low ventricular protrusion, and a flexible sewing cuff to facilitate secure implantation and minimize paravalvular leak. Its design incorporates individually selected porcine leaflets to ensure optimal coaptation and hemodynamic performance.
Product Code: E100 series
- Design: Stented Porcine Tissue Valve
- Material: Porcine Tissue Leaflets, Polymer Stent, Polyester Sewing Cuff
- Application: Mitral Valve Replacement
- Implantable
- Single-Use, Disposable
- Sterile
Additional Details
- Brand: Abbott (formerly St. Jude Medical)
- Category: Structural Heart / Surgical Heart Valves
- Type: Bioprosthetic Mitral Heart Valve
- FDA Product Code: LWR
- FDA Product Code Name: Heart-valve, non-allograft tissue
- GMDN Term Name: Mitral heart valve bioprosthesis
- GMDN Term Definition: A xenograft (e.g., porcine or bovine heart valve) intended to be implanted in a patient during open heart surgery to repair or replace a dysfunctional mitral heart valve. It is processed to render the tissue in the valve non-viable; it may be tissue only, or tissue attached to a metal or synthetic polymer framework. The device is typically used to treat acquired or congenital valvular disease.
Manufacturer
Abbott St. Jude Medical has long been a leader in vascular care, through its stents and related products. And, in recent years, the company has built a strong position in mitral valve repair with its MitraClip device. The agreement to acquire St. Jude Medical broadens Abbott's presence in virtually every aspect of cardiovascular care, and will make Abbott one of the world leaders in the broad medical device market.